Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

XIAFLEX - A New Treatment for Dupuytren's Contracture

February 6, 2010

Analysis of:XIAFLEX release approved by FDA | www.xiaflex.com

Auxilium (and BioSpecifics Technologies) have finally received approval for release of XIAFLEX, the first FDA approved nonsurgical treatment for Dupuytren's Contracture. XIAFLEX is injected directly into the Dupuytren's cord and enzymatically disrupts the collagen. When successful, the contracture is released and range of motion is improved.

Page : 11 to 1 of 1

Subscribe to Updates

By RSS